Target intelligence / Profile preview

Serotonergic system

Molecular classification
Other
01

Overview

The **serotonergic system** is not a single molecule or receptor, but rather a complex network comprising neurons primarily located in the raphe nuclei of the brainstem that synthesize and release the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT). This system includes multiple presynaptic and postsynaptic molecular components: serotonin receptor subtypes (such as 5-HT1 to 5-HT7 receptor families), the serotonin transporter (SERT), and various synthetic and metabolic enzymes like tryptophan hydroxylase and monoamine oxidase. Functionally, the serotonergic system modulates a wide array of physiological and behavioral processes including mood, arousal, sleep, appetite, pain processing, and cognition. Dysregulation of this system is implicated in neuropsychiatric and mood disorders including depression and anxiety. It is a major target for numerous therapeutic drugs, especially antidepressants, anxiolytics, and antimigraine agents[1][3][4]. **Important note:** - The query term "Serotonergic system" does *not* correspond to a single target molecule, receptor, or protein. Rather, it refers to an entire neurotransmitter system involving multiple molecular targets (receptors, transporters, enzymes). Therefore, it should not be used in databases that require molecular specificity or a single target entity. This makes "serotonergic system" an incorrect entry when compiling a molecular target list. The correct procedure is to specify one of its components, for example, "Serotonin receptor 1A (5-HT1A receptor)", "Serotonin transporter (SERT)", etc.[3][2].

Other names
serotonin system5-hydroxytryptamine system5-HT system
02

Mechanism of action

Modulation of serotonin receptors, Inhibition of serotonin reuptake, Inhibition of serotonin degradation, Agonism or antagonism at serotonin receptors

03

Biological functions

Signal transductionRegulation of moodRegulation of appetiteRegulation of sleepPain modulationRegulation of emotionAutonomic function
04

Disease associations

Neuropsychiatric disordersDepressionAnxietyMigrainePain disordersMood disordersOther
05

Safety considerations

Serotonin syndromeDrug-drug interactionsMood instabilityHyponatremiaSexual dysfunction
06

Interacting drugs

Selective serotonin reuptake inhibitors

9 more in the full profile.

07

Biomarkers

Serotonin transporter expression (SERT)Serotonin levels in plasma or cerebrospinal fluid

Beyond the preview

Go deeper on Serotonergic system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serotonergic system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call